News Release

WARSAW – OrthoPediatrics announced its financial results for the fourth quarter and full-year for 2021.

The company reported a record total annual revenue of $98.0 million for full-year 2021, up 38% from $71.1 million in 2020.

Domestic revenue increased 24% and international revenue increased 150% in 2021, the company announced.

“We are extremely proud of our 2021 performance and believe we have navigated through the pandemic very well – which we view as a testament to our durable business and strong commercial execution,” said David Bailey, President & CEO of OrthoPediatrics.

“Given COVID’s effect on children since September, we enter 2022 knowing the unshakable truth that there are more children who need our products than ever before. With the broadest product portfolio in the industry and our largest active surgeon base since inception, we are in a great position to recapture deferred procedures and help children in 2022 and beyond,” he said.

Click here to see the company’s entire report.